Bidda C. Rolin
Malov, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Liraglutide upregulates the Cftr gene and regulates the mucus transcriptome profile in Brunner's glands in mice.
Journal: Clinical and translational medicine
Published: May 26, 2025
Efficacy of a novel PCSK9 inhibitory peptide alone and with evinacumab in a mouse model of atherosclerosis.
Journal: Journal of lipid research
Published: July 05, 2024
In vitro cell cultures of Brunner's glands from male mouse to study GLP-1 receptor function.
Journal: American journal of physiology. Cell physiology
Published: April 20, 2022
Liraglutide Lowers Endothelial Vascular Cell Adhesion Molecule-1 in Murine Atherosclerosis Independent of Glucose Levels.
Journal: JACC. Basic to translational science
Published: March 14, 2022
The intestinal permeability marker FITC-dextran 4kDa should be dosed according to lean body mass in obese mice.
Journal: Nutrition & diabetes
Published: November 26, 2021
A neutralizing antibody against DKK1 does not reduce plaque formation in classical murine models of atherosclerosis: Is the therapeutic potential lost in translation?
Journal: Atherosclerosis
Published: May 25, 2020
Deep learning reveals 3D atherosclerotic plaque distribution and composition.
Journal: Scientific reports
Published: April 02, 2020
The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE-/- and LDLr-/- Mice by a Mechanism That Includes Inflammatory Pathways.
Journal: JACC. Basic to translational science
Published: April 19, 2018
Liraglutide Decreases Hepatic Inflammation and Injury in Advanced Lean Non-Alcoholic Steatohepatitis.
Journal: Basic & clinical pharmacology & toxicology
Published: April 10, 2018
Last Updated: 09/26/2026